FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.
This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.
AstraZeneca plc (LON:AZN) Ultomiris (ravulizumab) has been approved in the European Union for expanded use to include children (with a body weight of 10 kg or above) and adolescents with..
Weir Group PLC (LON:WEIR) has announced that Charles Berry will retire as Chairman following the 2022 Annual General Meeting (AGM), having completed his full nine-year term with the Board. The..
Barratt Developments PLC (LON:BDEV) has provided an annual results announcement for the year ended 30 June 2021. Commenting on the results David Thomas, Chief Executive of Barratt Developments PLC said:..
BHP Group plc (LON:BHP) has announced the appointment of Michelle Hinchliffe to the BHP Board as an independent Non-executive Director with effect from 1 March 2022. Ms Hinchliffe will also..
Melrose Industries PLC (LON:MRO) today announces its interim results for the six months ended 30 June 2021. Highlights Group ▪ Melrose is trading ahead of expectations, with better profit..
GlaxoSmithKline plc (LON:GSK) and SK bioscience have announced the initiation of a Phase 3 clinical study of SK’s COVID-19 vaccine candidate, GBP510, in combination with GSK’s pandemic adjuvant following positive..
Bunzl plc (LON:BNZL), the specialist international distribution and services Group, today publishes its half yearly financial report for the six months ended 30 June 2021. Financial results H1 21 H1..
AstraZeneca plc (LON:AZN) Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in Japan for the treatment of chronic kidney disease (CKD) in adults with and without type-2..
Positive high-level results from the PROVENT Phase III pre-exposure prophylaxis trial showed AstraZeneca plc (LON:AZN) AZD7442 achieved a statistically significant reduction in the incidence of symptomatic COVID-19, the trial’s primary..
Persimmon Plc (LON:PSN) has announced its half year results for the six months ended 30 June 2021. Dean Finch, Group Chief Executive, said: “Persimmon’s first half performance has been robust...
Just Eat Takeaway.com (LON:JET), hereinafter the “Company”, or together with its group companies “Just Eat Takeaway.com”, one of the world’s largest online food delivery marketplaces, has reported its financial results..
BT Group plc (LON:BT.A) has announced that Adam Crozier will succeed Jan du Plessis as Chairman. Adam will join the Board as an independent non-executive director and Chairman Designate with..
Coca-Cola HBC AG (LON:CCH), a growth-focused Consumer Packaged Goods business and strategic bottling partner of The Coca-Cola Company, has reported its financial results for the six months ended 2 July..
Avast plc, together with its subsidiaries (‘Avast’, ‘the Group’ or ‘the Company’), a leading global cybersecurity provider, announces its results for the six-months ended 30 June 2021. Ondrej Vlcek, Chief..
Phoenix Group Holdings PLC (LON:PHNX) has announced its 2021 half year results. Financial highlights Delivering cash · Strong cash generation1 of £872m in H1 2021 (H1 2020: £433m) has more than doubled..
InterContinental Hotels Group plc (LON:IHG) has announced its half year results to 30 June 2021. ● Significant improvement in demand over the course of H1, resulting in RevPAR (43)% vs..
Flutter Entertainment plc (LON:FLTR) has announced interim results for six months ended 30 June 2021. Reported1 Adjusted pro forma2 H1 2021£m H1 2020£m YoY % H1 2021£m..
Hargreaves Lansdown plc (LON:HL) has announced its results for the year ended 30 June 2021. Highlights: · Net new business of £8.7 billion · Strong growth in Assets Under Administration, up 30%..
AstraZeneca plc (LON:AZN) Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in the European Union (EU) for the treatment of chronic kidney disease (CKD) in adults with..
Hikma Pharmaceuticals PLC (LON:HIK), the multinational pharmaceutical company, has reported its interim results for the six months ended 30 June 2021. Siggi Olafsson, Chief Executive Officer of Hikma, said: “Once..
